Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Applied Therapeutics Inc | 1 | 1 | 0 | 0 | €7.02 | - | - |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €4.87 | - | - |
| Veracyte Inc. | 1 | 0 | 0 | 0 | €30.00 | - | - |
| Biolife Solutions Inc | 1 | 0 | 0 | 0 | €21.80 | - | - |
| Omeros Corp. | 2 | 2 | 0 | 0 | €3.49 | - | - |
| Immunogen Inc. | 1 | 0 | 0 | 0 | €28.97 | - | - |
| SELLAS Life Sciences Group Inc | 1 | 0 | 1 | 0 | €1.13 | €1.50 | 32.743% |
| Brainstorm Cell | 2 | 0 | 0 | 0 | €0.20 | €1.84 | 824.975% |
| Nektar Therapeutics | 5 | 1 | 1 | 0 | €1.20 | €2.99 | 149.525% |
| Rockwell Medical Inc. | 2 | 0 | 1 | 0 | €3.15 | €3.50 | 11.182% |
| Sangamo Therapeutics Inc. | 11 | 15 | 0 | 0 | €0.72 | €3.64 | 408.902% |
| Heron Therapeutics Inc. | 11 | 1 | 1 | 0 | €1.91 | €4.59 | 140.756% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 0 | 0 | €2.72 | €4.62 | 69.908% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.83 | €5.46 | 559.855% |
| Karyopharm Therapeutics Inc. | 8 | 1 | 0 | 0 | €0.81 | €5.49 | 579.842% |
| Geron Corp. | 15 | 0 | 1 | 0 | €3.96 | €5.55 | 40.182% |
| Chromadex Corp | 10 | 1 | 0 | 0 | €3.10 | €5.55 | 79.148% |
| Immunic Inc. | 8 | 3 | 3 | 0 | €1.47 | €6.43 | 337.024% |
| MannKind Corp. | 12 | 0 | 3 | 0 | €5.92 | €6.92 | 17.014% |
| Corvus Pharmaceuticals Inc | 5 | 2 | 2 | 1 | €4.72 | €6.94 | 46.972% |
| Personalis Inc | 11 | 1 | 1 | 0 | €4.72 | €7.29 | 54.335% |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €4.22 | €8.52 | 101.981% |
| Lexicon Pharmaceuticals Inc. | 12 | 0 | 3 | 0 | €1.54 | €9.07 | 490.717% |
| Cocrystal Pharma Inc. | 6 | 0 | 0 | 0 | €1.52 | €9.21 | 505.757% |
| Codexis Inc. | 8 | 1 | 1 | 0 | €2.88 | €9.84 | 241.328% |